We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

98% less funds holding

Funds holding: 517 → 8 (-509)

99% less call options, than puts

Call options by funds: $437K | Put options by funds: $45.7M

100% less capital invested

Capital invested by funds: $10.5B → $4.62M (-$10.5B)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 499

Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$14K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.29B
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.21B
3
BlackRock
BlackRock
New York
-$1.12B
4
State Street
State Street
Massachusetts
-$509M
5
Primecap Management
Primecap Management
California
-$370M
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
351
IEQ Capital
California
– -$303K -1,232 Closed
YC
352
Yarbrough Capital
Tennessee
– -$298K -1,212 Closed
BPCE
353
Bank Pictet & Cie (Europe)
Germany
– -$290K -1,181 Closed
GT
354
Glenmede Trust
Pennsylvania
– -$281K -1,150 Closed
RJFSA
355
Raymond James Financial Services Advisors
Florida
– -$283K -1,150 Closed
FTDI
356
First Trust Direct Indexing
Massachusetts
– -$281K -1,145 Closed
V
357
Veritable
Delaware
– -$281K -1,143 Closed
DTL
358
Dynamic Technology Lab
Singapore
– -$277K -1,129 Closed
C
359
Certuity
Florida
– -$277K -1,128 Closed
ZB
360
Zions Bancorporation
Utah
– -$274K -1,117 Closed
PP
361
Prudential plc
United Kingdom
– -$270K -1,098 Closed
TCM
362
Teza Capital Management
Illinois
– -$266K -1,083 Closed
BF
363
BOK Financial
Oklahoma
– -$265K -1,080 Closed
VI
364
Vestcor Inc
New Brunswick, Canada
– -$264K -1,074 Closed
LA
365
Legacy Advisors
Pennsylvania
– -$258K -1,049 Closed
CT
366
Chicago Trust
Illinois
– -$257K -1,047 Closed
MAM
367
Meeder Asset Management
Ohio
– -$254K -1,036 Closed
TF
368
TIAA FSB
Florida
– -$250K -1,017 Closed
GC
369
Grimes & Company
Massachusetts
– -$249K -1,014 Closed
PCM
370
Prelude Capital Management
New York
– -$249K -1,013 Closed
MC
371
Maverick Capital
Texas
– -$247K -1,007 Closed
MFAM
372
Motley Fool Asset Management
Virginia
– -$247K -1,006 Closed
AIM
373
Alhambra Investment Management
Florida
– -$246K -1,000 Closed
BCV
374
Banque Cantonale Vaudoise
Switzerland
– -$246K -1,000 Closed
CA
375
Centerpoint Advisors
Massachusetts
– -$246K -1,000 Closed
13 14
15
16 17

ABMD Hedge Fund Activity: Q4 2022 in Review

8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 499 funds closed out of ABMD and 0 opened new positions — a net loss of 499 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.

  • 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 517 in Q3 2022.
  • Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q4 2022 and 499 closed out, a net change of -499 holders.
  • The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
  • The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.

Based on aggregated 13F filings for Q4 2022.